|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
12.31(B) |
Last
Volume: |
409,225 |
Avg
Vol: |
473,087 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 12.5 |
Insider 3/6 Months : 13.1 |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
6,942 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$1,248,939 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
2 |
3 |
3 |
Total Buy Transactions |
0 |
2 |
3 |
5 |
Total Shares Sold |
23,114 |
39,618 |
49,144 |
90,567 |
Total Sell Value |
$5,787,506 |
$8,980,179 |
$11,008,736 |
$21,109,640 |
Total People Sold |
5 |
5 |
6 |
8 |
Total Sell Transactions |
7 |
10 |
16 |
26 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-05-15 |
4 |
S |
$190.39 |
$65,685 |
D/D |
(345) |
24,026 |
|
-4% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-05-12 |
4 |
S |
$193.02 |
$185,116 |
D/D |
(959) |
24,371 |
|
-4% |
|
Massaro George |
Director |
|
2023-05-11 |
4 |
AS |
$193.43 |
$55,708 |
D/D |
(288) |
4,964 |
|
7% |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-03-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
475 |
40,255 |
|
- |
|
Wallman Richard F |
Director |
|
2023-02-23 |
4 |
B |
$220.73 |
$386,278 |
D/D |
1,750 |
21,864 |
2.39 |
-9% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-02-22 |
4 |
D |
$243.60 |
$33,130 |
D/D |
(136) |
5,874 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2023-02-22 |
4 |
D |
$243.60 |
$441,890 |
D/D |
(1,814) |
214,780 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2023-02-22 |
4 |
D |
$243.60 |
$44,092 |
D/D |
(181) |
14,972 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2023-02-22 |
4 |
D |
$243.60 |
$69,913 |
D/D |
(287) |
8,476 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-02-22 |
4 |
D |
$243.60 |
$77,221 |
D/D |
(317) |
25,330 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-02-22 |
4 |
D |
$243.60 |
$12,424 |
D/D |
(51) |
7,838 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-02-22 |
4 |
D |
$243.60 |
$75,029 |
D/D |
(308) |
40,730 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-02-16 |
4 |
AS |
$246.02 |
$1,159,619 |
D/D |
(4,558) |
6,010 |
|
-19% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-02-16 |
4 |
OE |
$109.34 |
$498,372 |
D/D |
4,558 |
10,568 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-02-16 |
4 |
AS |
$246.13 |
$815,310 |
D/D |
(3,205) |
41,038 |
|
-19% |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-02-16 |
4 |
OE |
$109.34 |
$350,435 |
D/D |
3,205 |
44,243 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2023-02-15 |
4 |
AS |
$250.00 |
$5,000,017 |
D/D |
(20,000) |
216,594 |
|
-19% |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2023-02-01 |
4 |
D |
$248.21 |
$85,136 |
D/D |
(343) |
15,153 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2023-01-31 |
4 |
D |
$244.29 |
$657,629 |
D/D |
(2,692) |
15,496 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2023-01-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(21,453) |
232,922 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
49,725 |
254,375 |
|
- |
|
Creamer Victoria L |
EVP & Chief People Officer |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,229 |
18,188 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2023-01-27 |
4 |
D |
$244.29 |
$707,708 |
D/D |
(2,897) |
8,763 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,857 |
11,660 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-01-27 |
4 |
D |
$244.49 |
$320,037 |
D/D |
(1,309) |
6,010 |
|
- |
|
2014 Records found
|
|
Page 5 of 81 |
|
|